<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01153139</url>
  </required_header>
  <id_info>
    <org_study_id>124/2009BO1</org_study_id>
    <nct_id>NCT01153139</nct_id>
  </id_info>
  <brief_title>Long-term Bilateral Theta Burst Stimulation for the Treatment of Major Depression</brief_title>
  <acronym>TheBuS_D</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Repetitive transcranial magnetic stimulation has been shown to be moderately effective in the
      treatment of major depression. Theta burst stimulation (TBS) is a new form of rTMS that may
      exert larger effects.

      This sham-controlled study examines the effectivity of daily bilateral TBS to the
      dorsolateral frontal cortex over 6 weeks in 2x16 patients with major depression add on to the
      local standard of a combined pharmacological/psychotherapeutical treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of responders (response = decrease of the Montgomery-Åsberg Depression Rating Scale for at least 50%)</measure>
    <time_frame>after the end of treatment (week 6)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of the Hamilton rating scale for depression (HAMD 17)</measure>
    <time_frame>baseline, after the end of treatment (week 6)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the Beck Depression Inventory (BDI)</measure>
    <time_frame>baseline, after the end of treatment (week 6)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of the Montgomery-Asberg rating scale for depression (MADRS) score</measure>
    <time_frame>baseline, after the end of treatment (week 6)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Major Depression</condition>
  <arm_group>
    <arm_group_label>bilateral theta burst stimulation to the DLPFC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intermittent TBS (iTBS) to the left DLPFC continuous TBS (cTBS) to the right DLPFC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham stimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sham stimulation with a 45° tilted coil</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Repetitive Transcranial Magnetic Stimulation (Theta Burst Stimulation, TBS)</intervention_name>
    <description>intermittent TBS (iTBS) to the left DLPFC (600 stimuli, 80% resting motor threshold) continuous TBS (cTBS) to the right DLPFC (600 stimuli, 80% resting motor threshold)</description>
    <arm_group_label>bilateral theta burst stimulation to the DLPFC</arm_group_label>
    <arm_group_label>Sham stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  major Depression

          -  informed consent

        Exclusion Criteria:

          -  seizures in medical history

          -  metallic implants

          -  deep brain stimulation

          -  cardiac pacemaker

          -  brain trauma

          -  psychotic symptoms

          -  substance abuse

          -  pregnancy

          -  Benzodiazepines other than Lorazepam &gt;1mg/d
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Tübingen, Department of Psychiatry and Psychotherapy</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2010</study_first_submitted>
  <study_first_submitted_qc>June 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2010</study_first_posted>
  <last_update_submitted>July 13, 2013</last_update_submitted>
  <last_update_submitted_qc>July 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Christian Plewnia, MD</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <keyword>Depression</keyword>
  <keyword>Theta Burst Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

